MedTrace Logo

MMPPC Outpatient Clinical Protocol 2016

NCT02769884 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-01-30

No results posted yet for this study

Summary

This study trials a prototype artificial pancreas system that consists of a Roche insulin pump, a Dexcom continuous glucose monitor (CGM), and an experiential MMPPC (multiple model probabilistic predictive control) algorithm housed on an android cell phone. The system doses insulin based on CGM sensor glucose levels and the experimental algorithm.

The aim of this clinical study is to determine the efficacy of the MMPPC controller in adolescents and adults with type 1 diabetes in a hotel setting.

Conditions

Interventions

DEVICE

MMPPC algorithm artificial pancreas

An artificial pancreas system using the MMPPC algorithm, Roche insulin pump, and Dexcom CGM

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • Mount Sinai Hospital, New York

    collaborator OTHER

  • Rensselaer Polytechnic Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02769884 on ClinicalTrials.gov